APAC PET Scanners Market

Asia Pacific PET Scanners Market Size (2024 to 2029)

The size of the Asia Pacific PET Scanners Market was worth USD 288.12 million in 2024 and is estimated to be growing at a CAGR of 3.49%, to reach USD 342.03 million by 2029. 

Growing investments in R&D activities assist manufacturers design efficient treatments or pharmaceuticals to battle diseases like cancer, Alzheimer's disease, and other neurological disorders like epilepsy, which is another driving driver for the APAC positron emission tomography (PET) scanner market. Arsenic 72 and (18F)-3'-fluoro-3'-deoxythymidine (18F-FLT) are two newer PET oncology biomarkers. Different modalities of therapeutic procedures, such as chemotherapy, surgery, and radiation therapy, have evolved in cancer management. PET systems are widely utilized to provide complex images for further assessing the tumor's genesis and metastatic disease, and they are widely employed to provide reliable evaluation and diagnosis of tumor growth. Furthermore, the growing use of hybrid imaging techniques, combined with government reimbursements in this country, is creating prospects for PET scanner makers.

Obesity and cardiovascular diseases are examples of lifestyle-related disorders that have become an issue and are a primary cause of high mortality rates.

Hypertension, diabetes mellitus, overweight/obesity, and dyslipidemia are only a few of the critical risk factors that can lead to the development of cardiovascular disease. As a result, the rising frequency of lifestyle-related disorders has boosted demand for medical imaging, likely to drive PET system growth over the forecast period. Clinical trials, such as radiation planning using fluoro-deoxyglucose positron emission tomography (FDG-PET), are also projected to impact the industry in the future substantially. The investment rate has risen dramatically in recent years as the number of people employed by these businesses has grown.  

Furthermore, competitors in the market for positron emission tomography (PET) scanners have been focusing more on enhancing PET sensitivity, which necessitates 3D imaging and a broader axial field. To improve the overall quality of imaging and resolution, significant efforts have been undertaken to promote the adoption of positron emission tomography (PET) scanners for cardiac and respiratory patients. As a result, a growing number of positron emission tomography (PET) scanner manufacturers are concentrating on enhancing the quality of PET pictures by increasing spatial resolution and sensitivity while also improving spatial accuracy.

Shorter radioisotope half-lives and stringent regulatory guidelines are projected to stifle market growth during the forecast period.

This research report on the APAC PET Scanners Market has been segmented and sub-segmented into the following categories

Asia Pacific PET Scanners Market By Application

• Oncology 

• Neurology               

• Cardiology              

• Other Applications

Asia Pacific PET Scanners Market By Product Type

• Partial Ring PET Scanners 

• Full Ring PET Scanners

Asia Pacific PET Scanners Market By Detector Type

• Gadolinium Oxyorthosilicate           

• Lutetium Fine Silicate         

• Bismuth Germanium Oxide             

• Lutetium Oxyorthosilicate               

• Lutetium Yttrium Orthosilicate       

Asia Pacific PET Scanners Market By End Users

• Diagnostic Centres               

• Hospitals  

• PET Centres            

• Research Institutes      

Asia Pacific PET Scanners Market By Country

• India

• China

• Japan

• South Korea

• Australia

• New Zealand

• Thailand

• Malaysia

• Vietnam

• Philippines

• Indonesia

• Singapore

• Rest of APAC

Geographically, Asia Pacific has the third-largest market for PET Scanners globally by share. China has the largest market in the region.

Factors such as the growing aging population and rising demand for effective techniques are expected to drive the market growth in the region.Due to decreased healthcare expenditure on research and development, a large population base, and increasing demand for PET scanners, the Asia Pacific PET scanner market is expected to rise at a CAGR of over 15% through 2029. Rapid urbanization, combined with increasing GDP statistics in developed and emerging countries such as China, and others, have prompted governments to increase their investments in the healthcare sector, which is expected to drive the market for positron emission tomography scanners. Furthermore, the market for positron emission tomography scanners is likely to benefit from a vast pool of patients suffering from various malignancies, neurological and cardiovascular diseases. Development of new hardware, integration of designs with digital photomultipliers, and rapid electronics are only a few of the notable advancements that have enabled time-of-flight reconstruction to be implemented. In addition, factors such as leading manufacturers' increased focus on increasing their geographical presence in emerging Asia-Pacific countries to harness high growth potential are also contributing.

KEY MARKET PLAYERS

Some of the major players in the market are Positron Corporation, Mediso Ltd., Siemens AG, Hitachi Ltd., General Electric Co., Toshiba Corporation, Koninklijke Philips N.V., and Yangzhou Kindsway Biotech Co. Ltd., among others.